Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation–A single institution experience

Leukemia Research Reports(2022)10.1016/j.lrr.2022.100352Source: DataRank Database

Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation–A single institution experience is a research paper published in Leukemia Research Reports (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.30)OA: goldTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Charles Foucar ORCID,Anthony J. Perissinotti ORCID,Bernard L. Marini ORCID,Lydia L. Benitez ORCID,Patrick W. Burke ORCID

Live enrichment

PubMed:36247071 PMC:PMC9557030 OpenAlex:https://openalex.org/W4303444832

NIH

Grant: 5T32CA009357-39

Oncology Research Training Grant

FWCI

0.30

Citation Percentile

0.6%

Citation Trend

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S2213048922000644/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2213048922000644?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213048922000644?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.lrr.2022.100352

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36247071

Fields of Study

Chronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchEosinophilic Disorders and Syndromes03 medical and health sciences0302 clinical medicine

Keywords

MedicineInternal medicineDasatinibImatinibPhiladelphia chromosomeTransplantationHematopoietic stem cell transplantationIncidence (geometry)Stem cellLymphoblastic LeukemiaTyrosine-kinase inhibitorRetrospective cohort studyCohortGraft-versus-host diseaseOncologyGastroenterologyLeukemiaCancerChromosomal translocationMyeloid leukemiaSurvivalAcute lymphoblastic leukemiaStem cell transplantationComplete Molecular ResponseNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation–A single institution experience

FAIR Checklist

Authors (7)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)